在针对乳腺癌的新型miRNA中介方法的最新进展
Seyedeh Melika Ahmadi1, Shervin Amirkhanloo1, Rezvan Yazdian-Robati2
1Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Journal of drug targeting
|July 22, 2023
概括
微RNAs (miRNAs) 是乳腺癌发展和进展的关键参与者. 这项研究探讨了miRNA生物发生,功能和治疗潜力,以改善乳腺癌治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌 (BC) 是全球女性的主要癌症.
- 治疗的挑战包括耐药性,瘤异质性和转移.
- 乳腺癌干细胞有助于治疗失败和复发.
研究的目的:
- 审查乳腺癌中微RNAs (miRNAs) 的生物发生和功能.
- 探索miRNAs作为乳腺癌生物标记物的潜力.
- 讨论基于miRNA的乳腺癌治疗治疗策略.
主要方法:
- 关于乳腺癌中miRNA生物发生和功能的文献综述.
- 对报告异常miRNA表达在乳腺癌发病过程中的研究进行分析.
- 审查当前和新兴的miRNA向治疗方法.
主要成果:
- 异常miRNA表达与乳腺癌的发展和进展有关.
- 特定的miRNA显示出作为诊断和预后生物标志物的潜力.
- miRNAs可以被针对乳腺癌细胞的治疗干预.
结论:
- 了解miRNA的作用对于推进乳腺癌治疗至关重要.
- 基于miRNA的方法为更有效的乳腺癌治疗提供了有希望的途径.
- 向miRNAs可以克服与传统乳腺癌疗法相关的挑战.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


